Leflunomide

Product manufactured by Winthrop U.s.

Application Nr Approved Date Route Status External Links
NDA020905 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Leflunomide Is Indicated For The Treatment Of Adults With Active Rheumatoid Arthritis (Ra). Leflunomide Is A Pyrimidine Synthesis Inhibitor Indicated For The Treatment Of Adults With Active Rheumatoid Arthritis. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Leflunomide LEFLUNOMIDE ZINC4840

Comments